These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11701767)
21. Ivermectin, an unconventional agonist of the glycine receptor chloride channel. Shan Q; Haddrill JL; Lynch JW J Biol Chem; 2001 Apr; 276(16):12556-64. PubMed ID: 11278873 [TBL] [Abstract][Full Text] [Related]
22. Hyperekplexia mutation of glycine receptors: decreased gating efficacy with altered binding thermodynamics. Maksay G; Bíró T; Laube B Biochem Pharmacol; 2002 Jul; 64(2):285-8. PubMed ID: 12123749 [TBL] [Abstract][Full Text] [Related]
23. Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists. Rajendra S; Lynch JW; Pierce KD; French CR; Barry PH; Schofield PR Neuron; 1995 Jan; 14(1):169-75. PubMed ID: 7826634 [TBL] [Abstract][Full Text] [Related]
24. Hyperekplexia mutations of the glycine receptor unmask the inhibitory subsite for beta-amino-acids. Laube B; Langosch D; Betz H; Schmieden V Neuroreport; 1995 Apr; 6(6):897-900. PubMed ID: 7542038 [TBL] [Abstract][Full Text] [Related]
25. Mapping the agonist binding site of the GABAA receptor: evidence for a beta-strand. Boileau AJ; Evers AR; Davis AF; Czajkowski C J Neurosci; 1999 Jun; 19(12):4847-54. PubMed ID: 10366619 [TBL] [Abstract][Full Text] [Related]
26. Comparative surface accessibility of a pore-lining threonine residue (T6') in the glycine and GABA(A) receptors. Shan Q; Haddrill JL; Lynch JW J Biol Chem; 2002 Nov; 277(47):44845-53. PubMed ID: 12239220 [TBL] [Abstract][Full Text] [Related]
27. Thermophoretic analysis of ligand-specific conformational states of the inhibitory glycine receptor embedded in copolymer nanodiscs. Bernhard M; Laube B Sci Rep; 2020 Oct; 10(1):16569. PubMed ID: 33024136 [TBL] [Abstract][Full Text] [Related]
28. Alanine-scanning mutagenesis in the signature disulfide loop of the glycine receptor alpha 1 subunit: critical residues for activation and modulation. Schofield CM; Trudell JR; Harrison NL Biochemistry; 2004 Aug; 43(31):10058-63. PubMed ID: 15287733 [TBL] [Abstract][Full Text] [Related]
29. Binding-site mutations in the alpha1 subunit of the inhibitory glycine receptor convert the inhibitory metal ion Cu2+ into a positive modulator. Schumann T; Grudzinska J; Kuzmin D; Betz H; Laube B Neuropharmacology; 2009 Jan; 56(1):310-7. PubMed ID: 18793654 [TBL] [Abstract][Full Text] [Related]
30. Function of hyperekplexia-causing α1R271Q/L glycine receptors is restored by shifting the affected residue out of the allosteric signalling pathway. Shan Q; Han L; Lynch JW Br J Pharmacol; 2012 Apr; 165(7):2113-23. PubMed ID: 21955162 [TBL] [Abstract][Full Text] [Related]
31. Identification of Novel Functionally Important Aromatic Residue Interactions in the Extracellular Domain of the Glycine Receptor. Tang B; Devenish SO; Lummis SCR Biochemistry; 2018 Jul; 57(27):4029-4035. PubMed ID: 29947514 [TBL] [Abstract][Full Text] [Related]
32. The unique extracellular disulfide loop of the glycine receptor is a principal ligand binding element. Rajendra S; Vandenberg RJ; Pierce KD; Cunningham AM; French PW; Barry PH; Schofield PR EMBO J; 1995 Jul; 14(13):2987-98. PubMed ID: 7621814 [TBL] [Abstract][Full Text] [Related]
33. Identification of an inhibitory Zn2+ binding site on the human glycine receptor alpha1 subunit. Harvey RJ; Thomas P; James CH; Wilderspin A; Smart TG J Physiol; 1999 Oct; 520 Pt 1(Pt 1):53-64. PubMed ID: 10517800 [TBL] [Abstract][Full Text] [Related]
34. Charge and geometry of residues in the loop 2 β hairpin differentially affect agonist and ethanol sensitivity in glycine receptors. Perkins DI; Trudell JR; Asatryan L; Davies DL; Alkana RL J Pharmacol Exp Ther; 2012 May; 341(2):543-51. PubMed ID: 22357974 [TBL] [Abstract][Full Text] [Related]
35. Human glycine alpha1 receptor inhibition by quercetin is abolished or inversed by alpha267 mutations in transmembrane domain 2. Lee BH; Lee JH; Yoon IS; Lee JH; Choi SH; Pyo MK; Jeong SM; Choi WS; Shin TJ; Lee SM; Rhim H; Park YS; Han YS; Paik HD; Cho SG; Kim CH; Lim YH; Nah SY Brain Res; 2007 Aug; 1161():1-10. PubMed ID: 17603028 [TBL] [Abstract][Full Text] [Related]
36. A cation-π interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists. Pless SA; Hanek AP; Price KL; Lynch JW; Lester HA; Dougherty DA; Lummis SC Mol Pharmacol; 2011 Apr; 79(4):742-8. PubMed ID: 21266487 [TBL] [Abstract][Full Text] [Related]
37. Identification of a new ligand binding domain in the alpha1 subunit of the inhibitory glycine receptor. Vafa B; Lewis TM; Cunningham AM; Jacques P; Lynch JW; Schofield PR J Neurochem; 1999 Nov; 73(5):2158-66. PubMed ID: 10537076 [TBL] [Abstract][Full Text] [Related]
38. Effects of a mutation in the TM2-TM3 linker region of the glycine receptor alpha1 subunit on gating and allosteric modulation. Dupre ML; Broyles JM; Mihic SJ Brain Res; 2007 Jun; 1152():1-9. PubMed ID: 17434460 [TBL] [Abstract][Full Text] [Related]
39. The basic property of Lys385 is important for potentiation of the human α1 glycine receptor by ethanol. Castro PA; Figueroa M; Yevenes GE; San Martin LS; Aguayo LG J Pharmacol Exp Ther; 2012 Feb; 340(2):339-49. PubMed ID: 22040678 [TBL] [Abstract][Full Text] [Related]
40. Mechanism of gating and partial agonist action in the glycine receptor. Yu J; Zhu H; Lape R; Greiner T; Du J; Lü W; Sivilotti L; Gouaux E Cell; 2021 Feb; 184(4):957-968.e21. PubMed ID: 33567265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]